These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13729907)

  • 1. [Biochemical and pharmacological aspects of nialamide and comparison of it with other monoamine oxidase inhibitors (MAO)].
    NUNEZ-OLARTE E
    Rev Fac Med Univ Nac Colomb; 1960; 28():107-13. PubMed ID: 13729907
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of methylene blue on monoamine oxidase and the catechol amine and 5-hydroxytryptamine metabolism of the brain].
    EHRINGER H; HORNYKIEWICZ O; LECHNER K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 241():568-82. PubMed ID: 13726011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of nialamide on monoamine exidase (MAO), epinephrine and glycogen in the rat placenta].
    Kulay L; Longhi L
    Riv Ital Ginecol; 1974 Nov; 55(6):467-70. PubMed ID: 4463456
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of monoamine oxidase inhibitors on the metabolism of serotonin and epinephrine.
    FELDSTEIN A; HOAGLAND H; RIVERA MR; FREEMAN H
    J Neuropsychiatr; 1961; 3():83-4. PubMed ID: 13892161
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish.
    Sallinen V; Sundvik M; Reenilä I; Peitsaro N; Khrustalyov D; Anichtchik O; Toleikyte G; Kaslin J; Panula P
    J Neurochem; 2009 Apr; 109(2):403-15. PubMed ID: 19222706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
    CONSBRUCH U; FAUST C
    Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunodetection of the serotonin transporter protein is a more valid marker for serotonergic fibers than serotonin.
    Nielsen K; Brask D; Knudsen GM; Aznar S
    Synapse; 2006 Apr; 59(5):270-6. PubMed ID: 16408260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in the action of monoamine oxidase inhibitors.
    PLETSCHER A; GOSCHKE H; GEY KF; THOLEN H
    Med Exp Int J Exp Med; 1961; 4():113-7. PubMed ID: 13736341
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitors of monoamine oxidases: pharmacological properties and clinical effects of beta-phenylisopropylhydrazine and of nialamide].
    GRATTAROLA FR; ROVERA GG
    Riv Patol Nerv Ment; 1960; 81():303-18. PubMed ID: 13707969
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in biochemical and pharmacological effects observable after inhibition of monoaminoxidase (MO)].
    CANAL N; MAFFEI-FACCIOLI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1959 Apr; 35(8):436-9. PubMed ID: 13662420
    [No Abstract]   [Full Text] [Related]  

  • 14. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of amine oxidase inhibitors on epinephrine metabolism in man.
    RESNICK O
    Ann N Y Acad Sci; 1959 Sep; 80():726-33. PubMed ID: 14437447
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide].
    PRATESI G; MUZZOLINI M
    Minerva Med; 1959 Dec; 50():4447-53. PubMed ID: 14434665
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
    Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
    J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.